© Copyright Nostre Net
The eyelashes enhancing agents market has been growing rapidly, witnessing continued demand over the last few years. A massive craze can be seen in the market for eyelash serums that promise to strengthen and lengthen those thin hair. To meet this demand, there is also an influx of eyelash enhancing products available in stores. Eyelash enhancers have become more popular due to their effective functional feature that turns dull, brittle, and sparse lashes into attractive and long eyelashes.
Increasing awareness and consciousness towards presentable appearance, beauty, and fashion among consumers would continue to drive the global eyelashes enhancing agents market in the years to come. Moreover, the availability of these cosmetic products in various forms is expected to keep garnering popularity for eyelashes enhancing agents among fashion enthusiast.
According to Market Research Future (MRFR), the global eyelashes enhancing agents market is expected to reach USD 513.44 MN by 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of 5.83% throughout the forecast period (2017-2023). Bourgeoning fashion and media & entertainment industry is impacting the market growth, positively.
Major Players:
Players leading the eyelashes enhancing agents market include Allergan Plc., Estee Lauder, Rodan & Fields, LLC, Athena Cosmetics, Inc., Skin Research Laboratories, Beauty Essentials LLC, and Grande Cosmetics, LLC, among others.
On the other hand, eyelashes enhancer agents sometimes may affect adversely depending upon the consumers’ skin type. Some consumers experience severe side effects, including changes in iris color, itchy eyes, eyelid drooping, eye/lid discoloration, thinning & loss of eyelashes, eye sensitivity, eye infections, eyelashes size and vision impairment as well. Side-effects of eyelashes enhancer agents can be a major factor impeding the growth of the market.
Eyelashes Enhancing Agents Market – Segments
By Types : Curling, Lengthening, and Volumizing, among others.
By Application : Repairing Damaged Eyelashes and Nourishing, among others.
By Content : Bimatoprost, Lash-Building Serum, Herbal Remedy, Isopropyl Cloprostenate, Enhancer Serum, and Skincare Ingredients, among others.
By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).
Eyelashes Enhancing Agents Market – Regional Analysis
North America dominates the global eyelashes enhancing agents market with the largest market share. Factors influencing the regional market growth include the presence of well-established cosmetic industry and many strong players. Moreover, the focus of research institutions on updating technology for new & advanced eyelashes enhancing agents and massive development in the cosmetic industry led by the high per capita income drive the growth of the market. The region is further expected to reach USD 234.59 MN by 2023.
Europe takes the second-leading position in the global eyelashes enhancing agents market. Based on a potential application in the fashion sector, eyelashes enhancing agents have gained colossal prominence in the region. Besides, well-established fashion industries in Milan and Paris impact the market growth in the region, positively. Also, growing cosmetic industry, well-developed technology, changing lifestyle, and increasing demand for eyelashes enhancing agents driven by the improving economy foster the regional market growth.
The eyelashes enhancing agents market in the Asia Pacific region is emerging as a promising market, globally. The burgeoning fashion, media, and entertainment industry in India is the most significant driving force. Besides, the rapidly growing cosmetic sectors in developing nations present in this region, like India and China are encouraging the growth of the regional market. Asia Pacific is further expected to grow at a 6.26% CAGR during the forecast period.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Overview:
Hospital beds are a special type of bed that have been designed to serve the hospitalized patients. These beds can be both electric and semi-electric ones. The global hospital beds market is gaining high traction due to the increase in geriatric population and people suffering from diseases. The global hospital beds market has the potential to cross the valuation of USD 4824.2 million by the end of 2023 with a moderate CAGR of 5.5% during the forecast period of 2017 to 2023. Market Research Future (MRFR) in their latest analysis of the global hospital beds market report opens up potentials that can impact the market in the coming years.
Several factors are expected to take the global hospital beds market ahead. Hike in investment for the healthcare sector is expected to play in favor of the global hospital bds market. Patient-centric service is also expected to ensure strong growth for the market as managements are going to buy new ones to increase the level of comfort for the market. However, the high price can be a growth deterrent.
Competitive Landscape:
Various market players are showing substantial interest in the global hospital beds market. The global market can be inspired by the strategic moves implemented by these companies to cement their individual growth and in the process, they are taking the global market ahead. MRFR, in their report on the market, profiled quite a few companies. These companies are by Stryker Corporation, Hill-Rom Holdings, Invacare Corporation, Linet spol. s r.o., Gendron Inc., Paramount Bed Holdings Co., Ltd., and Getinge AB.
Segmentation:
MRFR has made an attempt to read the global hospital beds market closely by segmenting it on the basis of type, power, and end-users. This analysis has a strong foundation in the volume-wise and value-wise analysis of the global market.
Based on types, the global hospital beds market includes long-term care, acute care, psychiatric & bariatric care, and others (maternity and rehabilitation beds). The global smart hospital beds of the future market is expecting strong growth from the long-term care segment.
By power, the hospital beds market comprises electric bed, semi-electric bed, and manual bed. The electric bed segment is expected to receive strong traction due to hike in the global healthcare expenditure and investment to increase level of comfort for patients.
By end-users, the global hospital beds market includes hospital, clinics, ambulatory, and others. The hospital segment is expected to grow notably.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are four regions that have been included in the global hospital beds market report, studied by MRFR. This report has a special focus on the growth pockets that can be explored later for a better understanding of the market flow.
Europe is dominating the global market that depends mostly on the contribution made by Western Europe where countries like France, Germany, the U.K, Spain, Italy, and others are doing great. The eastern region does not promise high growth as several countries are there with not much of strong economies. The Europe hospital beds market had a valuation of USD 916.6 million in 2016 and is at present, deemed to grow with a CAGR of 5.5% during the forecasted period.
The Americas stands in the second spot. This growth is due to robust infrastructure, huge geriatric population, substantial investment capacity, high per capita income, and other features. It is also getting the benefits of the presence of countries like the U.S. and Canada who spend substantially to take the regional market ahead.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Scenario
The market for dental infection treatment is projected to reach USD 20.5 BN growing at a CAGR of 8.6 % during the forecast period (2017-2023), estimates Market Research Future (MRFR). The market for dental infection treatment is on a constant rise due to poor dental hygiene, sedentary lifestyles, lack of dental health awareness, and absence of flossing. High sugar diet and junk foods cause dental infection, whereas consumption of sodas lead to rise in cavities due to the weakening of the natural physical barrier of the teeth. Moreover, advancements in technologies and reimbursement for medicines also boost the market growth and will continue to do so in the coming years. Also, consumption of some medical drugs like anti-depressants and blood pressure medicines cause dental infection, which increases the demand for dental infection treatment.
Various trends making its way in the market are 3D dentistry, dental implants, professional cleaning and use of stainless steel crowns (SSC) for quick healing. Extended services will also be provided by dentists, with other professionals joining their team., for instance, a licensed nutritionist wanting to practice nutritional counseling after dental procedure. These trends provide opportunities within the dental infection treatment market to attract large number of patients and also lead to customer retention as well.
Key Players
The key players in the dental infection treatment market are Kerr Corporation, Patterson Dental Supply, Inc., Henry Schein, Inc., Taj Pharmaceuticals Limited, Septodont Healthcare India Pvt. Ltd., Bayer HealthCare, Ultradent Products Inc., and Bristol-Myers Squibb and many more.
Market Segmentation
The global dental infection treatment market is segmented into by type, treatment, and end users. The By type, segment of the market is segmented into periapical abscess, periodontal abscess, and others. Conditions like such as bruxism, occlusal overload, and rise in diabetes which predisposes a patient to the formation of periodontal abscess, lead to can drive the growth of periodontal abscess treatment market segment.
Various forms of treatments are drugs, which are antibiotics or pain killers, and procedures such as root canal, tooth fillings, tooth extraction, dental implant tools and many more others. Root canal procedures are pain-free, efficient, cost-effective and are long lasting, these factors drive the appeal for root canal treatment among patients, in turn fuelling the growth of root canal treatment market. On the other hand, demand for tooth extraction treatments is on the rise due to the facilitation of orthodontic treatment surgery, and reduced cost compared to other treatments.
The End users of in the dental infection treatment market are dentistry clinics, hospitals, and others.
Regional Analysis
Geographically, the dental infection treatment market is geographically segmented into North America, Europe, Asia -Pacific (APAC), and the Middle-East and Africa.
Among all regions, the United States (U.S) in North America holds the maximum market share due to extensive use of medications and greater expenditure on healthcare. Emergence of new technology technologies and devices in the U.S. also drives the market for global dental infection treatment. The presence of large device companies helps to establish the dental infection treatment market in this region. This region is hugely lucrative for manufacturers in the dental infection treatment market owing to a large consumer base. Also In addition, growing number of emergency rooms (ER) for dental care, ability to afford dental treatment services, and increasing per capita can enhance the demand for dental infection treatment market in this region.
On the other hand, after North America, Europe is the largest market owing to sizeable disposable income coupled with rising awareness about dental health hazards. Also, easy access to dental care services and increasing number of dental clinics and infrastructure help establish the can allow players to penetrate the market in this region easily.
The Middle East & and Africa dental infection treatment market is governed by the Gulf nations such as Saudi Arabia and the United Arab Emirates (UAE). Advancements in technology like non-invasive treatments in dentistry, growing cases of detrimental dental health due to cavity, and constant research and developments to enhance the dental infection treatment experience can drive the market growth in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Skin grafting involves the transplantation of skin graft from a healthy part of the body (donor) to the damaged part (acceptor).
Considering all these factors the market for skin graft is expected to reach $ 7.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 13.5 % during 2017-2023.
Market dynamics of Global Skin graft Market:
The market for skin graft is rising due to factors such as rise in the cases of accidents, burns and surgeries, infection such as necrotizing fasciitis or purpura fulminans, cancer. The market restraints are complications such as infection, pain, graft rejection and cost of treatment.
Key players of Global Skin graft Market:
Key players profiled in the report are Organogenesis, Inc., Specmed Medical, Stratatech Corp, Tissue Regenix Group PLC, Avita Medical, Convatec Inc, Medrotonic, Coloplast, B.Braun Melsungen, zimmerbiomet, Stratatech Corporation, Zimmer Biomet and others.
Segments of Global Skin graft Market:
The global skin graft market is segmented on the basis of graft type, graft thickness and applications. Graft type - autologous, isogeneic, allogeneic, xenogeneic and prosthetic.
Graft thickness - split-thickness, full-thickness and composite graft.
Applications - extensive wound, burns, extensive skin loss due to infection, skin cancers and others. Equipment - dermatome (knives dermatomes, drum dermatomes, electric dermatomes, air dermatomes), general surgical instruments, consumables and others.
End users - hospitals and clinics, academic and research and others.
Regional analysis of Global Skin graft Market:
US accounts for the maximum market share due to favourable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global dermatology and skin surgery. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration. However it has to be noted that although the demand for skin graft is quite high in developed countries like the U.S., Latin American countries such as Venezuela, Brazil and others have a disproportionate share of market considering their low income as compared to the U.S. The market of these nations is influenced to a considerable degree by the tourism and fashion industry. Advertisement and greater exposure seems to be the best strategy to be a market leader along with product development. Thus the market represents a clustered outlook.
Current trends and developments
Thus product development reflects the best strategy for the development of the market. Another strategy has been collaboration between large hospitals and companies. The collaboration benefits both players as the company achieves feedback data while the hospital benefits from reduced price and better service conditions.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The amplified detection rate of injuries related to bone and tendons is powering the tendinitis treatment market. Reports that examines the pharmaceutical industry has been offered by Market Research Future, which produces reports on industry verticals that evaluate the market development and opportunities. The market is anticipated to gain a CAGR of 3.8% approximately while earning USD 426.4 million by 2023.
The launch of novel treatments and therapies are expected to have a significant role in the expansion of the tendinitis treatment market. Moreover, the surge in tendinitis cases is also influencing the progress of the chronic tendonitis treatment market in the upcoming period.
The distinguished players in the tendinitis treatment market are AstraZeneca (US), Bayer (Germany), Pfizer (US), Boehringer Ingelheim Pharmaceuticals, Inc. (US), Almatica Pharma, Inc. (US), Merck & Co., Inc (US), and others.
Competitive Analysis
The need to establish cost-benefit analysis is leading to enhanced product development in the market. The market players are concentrating on strategies that lead to the highest degree of development in the market. The market competitors are also carefully scrutinizing whether intervention is required to ensure efficient use of society’s resources. The development of the alternative courses of action in terms of both their expenses and consequences are steering the growth of the market. The state of the assets is also thoroughly examined to determine whether an investment is required to maintain the marketing system in its existing, unimproved state. The trade-offs between the resources needed to manage the challenges in the market are being carried out increasingly to improve the market’s scope for development. They are also making the most effective use of resources which is dependent on an effective appraisal and planning process.
Segmental Analysis
The segmentation of the tendinitis treatment market has been segmented on the basis of condition, diagnosis, treatment, end-user, and region. Based on the condition, the tendinitis treatment market comprises of golfer's elbow, tennis elbow, jumper's knee, pitcher's shoulder, swimmer's shoulder, and others. Based on the diagnosis, the tendinitis treatment market is segmented into imaging tests, physical exam, and others. The imaging test is sub-segmented into magnetic resonance imaging (MRI) scans, ultrasound, and others. The treatment-based segmentation of the tendinitis treatment market been segmented into therapy, medications, surgical repair, and others. The medication sub-segmented into corticosteroids, pain relievers, platelet-rich plasma (PRP), and others. The therapy segment is additionally sub-segmented into physical therapy, hot and cold therapy, occupational therapy, and others. By end-user, the tendinitis treatment market is segmented into medical research centers, hospitals & clinics, academic institutes, and others. The region-based segmentation of the tendinitis treatment market comprises of the Middle East, Europe, Asia Pacific, Africa, and North America.
Detailed Regional Analysis
The regional assessment of tendinitis treatment market includes regions such as the Middle East, Europe, Asia Pacific, Africa, and North America. With regards to the global scenario of the market, the Americas region is the maximum contributor in this market. The Americas mainly consist of regions such as North America and South America. Owing to established healthcare infrastructure and growing R&D backing. The US is controlling the market in this region. The European region is the second principal market for tendinitis treatment. The innovative product development and speedy adoption of new treatments have led to Germany leading the market. Moreover, the Asia Pacific region is seeing rapid development in this market, which is primarily due to the speedily moving healthcare sector, intensifying awareness, and expanding healthcare expenditure. The Middle East and African region are anticipated to have restricted growth while Middle Eastern nations are projected to govern this market throughout the forecast period.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Dental Amalgam has long been the popular cavity filling choice for dentists because of its strength and durability. A cavity is a common dental problem caused by a build-up of plaque, a sticky substance made up of bacteria. Due to the widespread cavity concerns, dental amalgam witnesses a huge demand all over the world. Resultantly, the dental amalgam market is growing pervasively on the global platform.
Considering the kind of the growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global dental amalgam market will reach up to USD 500 MN by 2023 with approx. 5% CAGR during the review period (2017 – 2023).
Silver amalgam fillings that have been a staple of dentistry since decades consist of approximately 50 percent mercury, a known toxin that can cause harmful effects in humans. Despite the presence of mercury, the U.S. FDA considers amalgam fillings safe for adults and children over six years old.
Key Players:
Some of the eminent leaders of the market include Patterson Dental, DMP Dental, APL Materials, Nanjing FoiNoe Co., Ltd., DMP, AT&M Biomaterials Co., Ltd., Kerr Corporation, BOME, Benco Dental Supply Company, and Henry Schein, Inc.
Besides, composites offer superior bonding capabilities to the tooth structure. The emergence of composite fillings has given rise to the market, increasingly encouraging people to opt for the Amalgam, which in turn, augments the market demand for dental amalgam.
The cosmetic dentistry treatment market also supports the dental amalgam market. Furthermore, growing oral healthcare concerns worldwide, fuel the market growth predominantly. Increasing awareness among people about oral health plays a major role in fostering the market growth.
Additional factors substantiating the market growth include the growing population including increasing geriatric populace and urbanization. Improving economic conditions across the globe provide impetus to the market growth, enabling access to the quality of life with the improving healthcare. Seminal efforts and investments by the market players to develop innovative Amalgam materials and to bring betterment in their existing materials are paying off well, driving the market growth.
On the other hand, factors such as inadequate reimbursements for dental amalgam are expected to inhibit the market growth, especially in the developed economies. Nevertheless, the emergence of cost-competitive composite amalgam material is expected to support the market growth.
Global Dental Amalgam Market – Segmentations
By Particle Shape : Lath Cut Particles, Spherical Particles, and Admixed Particles among others.
By Particle Size: Micro Cut, Fine Cut, and Coarse Cut among others.
By Metals: Noble Metals (gold, silver, other), and Non-noble Metals (copper, gallium, others) among others.
By Number of Alloy Metals: Binary Alloy, Ternary Alloy, and Quaternary Alloy among others.
By Regions: North America, Europe, APAC and Rest-of-the-World.
Global Dental Amalgam Market – Geographical Analysis
Geographically, the North American region accounts for the leading market for dental amalgam, capturing the largest market share followed by the European & Asia Pacific region, respectively. High expenditure on health care is the main driving force for the market growth in North America. Moreover, burgeoning market in the US backed by the substantial investments significantly contributes to the market growth in the region.
Additionally, increasing demand for dental amalgam due to the prevailing dental problems such as tooth decay provides impetus to the market growth. Continuing with the same trends, the North America dental amalgam market is expected to create a larger revenue pocket in the global market by 2023.
The European region is the world’s second-largest market for dental amalgam. The market is driven by the high per capita health care expenditures and well-established healthcare sector in the region. Countries such as the UK, Germany, and France backed by the huge investments drive the regional market growth at a large scale. With the increasing investment in health care and the rising number of patients with dental diseases, the dental amalgam market in Europe is projected to register a phenomenal CAGR during the assessment period.
The Asia Pacific dental amalgam market is expected to perceive an exponential growth, emerging as a promising market for the product. Growing markets of India & China backed by the vast population and the burgeoning medical treatment foster the market growth in the region. Furthermore, Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Synopsis:
Electrotherapy is a type of treatment in which electrical impulses are used in stimulating nerves and muscles for multiple purposes which majorly includes pain management, stimulation of muscle contraction, stimulation of physiochemical changes in the body and others.
The use of electrotherapy for various therapeutic purposes is increasing, hence driving the growth of the global electrotherapy market. Market Research Future (MRFR), a firm that excels in healthcare sector among others, has recently published a report on electrotherapy market asserting that the global electrotherapy market is anticipated to reach US$ 1119.1 million at a noteworthy CAGR of ̴4.2% from 2016 to 2023. The report majorly focuses on various segments that are driving this market and has provided the current opportunities, challenges as well as the restraints affecting the growth of global electrotherapy market.
The inclination of physiotherapists and athletic trainers is more towards the inclusion of electrotherapy system as an adjunct to the traditional physiotherapy treatment. The rapid adoption of advanced technology in the healthcare sector is increasing the demand for electrotherapy system in the market. The increase in the incidence of spinal injuries and growing prevalence of diabetes and obesity are some of the factors fuelling the expansion of global electrotherapy market. The rapid inclusion of electrotherapy system for re-education after nerve injury or trauma, to reduce muscle damage due to immobilization and to increase the production of vitamin D and corticosteroids is driving the global electrotherapy market to reach higher verticals.
Key Players of Global Electrotherapy Market:
Some of the prominent players in the global electrotherapy market are BTL (Czech Republic), Eme Srl (Italy), EMS Physio Ltd. (UK), Enraf-Nonius B.V.(Netherlands), gbo Medizintechnik AG (Germany), MEDTRONIC (Republic of Ireland), Omron Healthcare, Inc.(US), Phoenix Healthcare (UK), Pure Care (US), STYMCO Technologies, LLC (US), Walgreen Co. (US), and others.
Market Segmentation:
The Global Electrotherapy Market has been segmented on the basis of type, devices and application. On the basis of types, the electrotherapy market is segmented into extracorporeal shock wave therapy, interferential, magnetic field therapy (constant energy magnets, pulsed electro-magnetic field energy), ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy (conventional TENS, acupuncture-like TENS (AL-TENS), intense TENS), and others.
On the basis of devices, the global electrotherapy market is segmented into transcutaneous electrical neural stimulator (TENS), electronic muscle stimulator (EMS), interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), micro-current stimulator (MC) or micro-current electrical neuromuscular stimulator (MENS), and others.
On the basis of application, the global electrotherapy market is segmented into orthopedics, cardiology, urology, pain management (chronic pain, chronic fatigue, migraine headaches, wound healing, diabetic nerve pain, stimulating bone growth), acute and chronic edema, and others.
Detailed Regional Analysis:
Regionally, the global electrotherapy market is segmented into North America, Europe, Asia-Pacific (APAC) and Middle East and Africa. Due to the increasing adoption of electrotherapy system in sports injury treatments and other purposes, North America is currently the largest market for electrotherapy. The use of electrotherapy as rehabilitation and preventive tool for partially or completely immobilized patients is driving the market in the European region. On the other hand, Asia-Pacific region is considered to be the fastest growing electrotherapy market and it may out-run North America for being the largest market by the end of 2023. Whereas, Middle-East and Africa are likely to have limited growth in the electrotherapy market due to the lack of awareness of the treatment and devices.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
The Middle-East and Africa Stroke Diagnosis and Treatment Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Stroke affects blood supply to brain. Blood vessel that carries oxygen and nutrients to the brain is either blocked by a clot or bursts is the cause of stroke. Due to this brain cells starting to die. Ischemic strokes occur due to narrowing or blocking of arteries to the brain while Hemorrhagic strokes are caused by blood vessels in and around the brain bursting or leaking. There are some symptoms like problem in speaking, inability to move etc.
Middle-East and Africa Stroke Diagnosis and Treatment Market was estimated around US$ 186.4 million in 2015 and is expected to reach US$ 289.7 million by 2022 at a CAGR of 6.5%. There are several factors which are prohibiting the growth of the market such as high cost of treatment and drugs, lack of early treatment, lack of awareness and healthcare facilities particularly in African countries etc.
Stroke Diagnosis and Treatment Market Players:
There are plenty of large and small market players which operates in Middle East and Africa market as well as all over the globe. King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), Abbott (US), Johnson & Johnson Services, Inc. (US), GE Healthcare (UK), Koninklijke Philips N.V. (Netherlands), Hitachi, Ltd. (Japan)
Regional Analysis:
Considering the Middle-East and Africa Stroke Diagnosis and Treatment Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Stroke Diagnosis and Treatment. Moreover Saudi Arabia market is also growing and second largest market for Stroke Diagnosis and Treatment. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Stroke Diagnosis and Treatment during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Segmentation:
Middle-East and Africa Stroke Diagnosis and Treatment market has been segmented on the basis of type which comprise Ischemic strokes, Hemorrhagic strokes, and others. On the basis of diagnosis the market is segmented into Blood tests, Computerized tomography scan, Magnetic resonance imaging, Carotid ultrasound, cerebral angiogram, Echocardiogram, and Others. On the basis of stroke treatment it is segmented into cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty and stents, Surgical AVM removal, Intracranial bypass, Stereotactic radiosurgery, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Overview:
The global osteoporosis market is currently eyeing for a staggering USD 14,300 million valuation during the forecast period (2013-2022), claims Market Research Future (MRFR) in a detailed study. Booming urbanization and technological advancements may have a lot to do with the progressing world, but they have some adverse effects too. Osteoporosis is one such side-effect of the fast-evolving lifestyle and the inflating osteoporosis drugs market is a direct result of that. The market is about to witness a moderate CAGR of 4.7% during the forecast period.
Drivers and Restraints:
Adoption of a sedentary lifestyle triggered by work-related pressures and technological advancements is also one of the chief driving force for the osteoporosis drug market. Furthermore, women are more prone to this disease. This has given rise to awareness and technological and medical awareness which also giving the market a much-needed thrust.
However, blockbuster drugs losing patents, generic drugs penetrating the market and creating fragments in the market, and side-effects of present therapies can bottleneck the market growth. But patients are now quickly realizing its importance and how it can lead to further damages such as hip fractures which will bring back the wind in the market’s favor.
Market Dashboard:
The market is mainly getting driven by mergers and acquisitions. For instance, Novartis has recently acquired AveXis, Inc. On the other hand, F. Hoffmann La Roche Ltd. reached an agreement with Foundation Medicine regarding a definitive merger.
Some of the key players in this market are Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical Industries Ltd. and others.
Segmentation:
The global market for osteoporosis drug market can be segmented by drug class, route of administration and gender.
By osteoporosis medications, the market can be segmented into bisphosphonates, calcitonin’s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. Bisphosphonates are currently leading the market. The drug is the most commonly prescribed medicine resulting in the medicine capturing almost half of the market.
On the basis of route of administration, the market comprises oral, injectable and others.
Based on gender, the market comprises male and female. However, women are more prone to this disease. As per the studies of the International Osteoporosis Foundation (IOF), worldwide over a billion women are now suffering from the disease.
Regional Analysis:
The global osteoporosis drug market covers the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas has the largest market owing to a rising geriatric population and advanced healthcare setup. Also, the reimbursement policies are pretty patient-friendly resulting in the growth of the market. People here are more aware of the consequences, that is why they prefer timely action. Hence, the market is snowballing.
Europe is second in the market and technologically advanced healthcare sector is proving to be a boon for the market. Rising number of population with disposable income and easy reimbursement policies act as a market booster.
The APAC comes next where China and India are expected to play significant role. These two countries have a huge population base, and the market is benefitting much from their very well-structured healthcare sector.
The MEA is expecting the least growth. Healthcare sector is not that developed, and people act ignorant. Reimbursement policies are not that well-formed. These are factors holding the market back.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Overview
As per the reports published by Market Research Future (MRFR), the worldwide ulcerative colitis market has been recorded as a growing market. The market can be estimated to generate remarkable worth in the coming future. Ulcerative colitis is a category of inflammatory bowel disease (IBD) that mostly impacts the lower region of the body such as the rectum and sigmoid colon. Diarrhea, bleeding from the rectum, belly pain, and cramps are some of the common signs of ulcerative colitis market. As per the studies conducted by the Centers for Disease Control, global prevalence of ulcerative colitis has been recorded to be witnessing 0.5 to 24.5 cases per 100,000 people every year. Chances of recurrence of the ailment’s signs is also high. The Colitis Foundation of America stated that almost 30% of people on remission are likely to suffer from the ailment seethe in the future, right after the cure and remission.
Key Players
Global ulcerative colitis market has been dominated by key players such as AbbVie Inc., Allergan, Inc., UCB S.A., Pfizer Inc., Takeda Pharmaceutical Company Limited, Ferring B.V., Bayer AG, Perrigo Company plc, Janssen Biotech, Merck, and Johnson & Johnson Services, Inc.
Market Segmentation
Global ulcerative colitis market has been segmented based on medication and type. Based on medication the market has been segmented into steroids, 5-aminosalicylates, immunomodulators, biologics, and purine analogs. Biologics are estimated to hold the largest market share. Steroids drugs are likely to expand at the highest CAGR over the forecast period. Based on types, the market has been segmented as proctosigmoiditis, ulcerative proctitis, research ulcerative colitis, pancolitis or universal colitis, fulminant colitis, and left-sided colitis. Ulcerative proctitis has been estimated to hold the largest market share over the forecast period.
Regional Analysis
In 2016, North America was projected to account for the largest share of the worldwide ulcerative colitis market followed by Europe. The region is likely to continue dominating the pack over the forecast period. In the Asia-Pacific region, China leads the ulcerative colitis market. Improvement of healthcare facilities coupled with economic development are accelerating the development of the market.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America